EOM Pharmaceutical Holdings, Inc. (IMUC)
(Delayed Data from OTC)
$0.20 USD
0.00 (0.00%)
Updated Apr 26, 2024 02:19 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
EOM Pharmaceutical Holdings, Inc. [IMUC]
Reports for Purchase
Showing records 81 - 90 ( 90 total )
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Additional ICT-107 Results Highlight 2Q11
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: BERNARDINO V
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Buy Promising New ICT-107 Data Presented at ASCO
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: BERNARDINO V
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Initiating Coverage with a Buy Rating and Price Target of $5
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: BERNARDINO V
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: EOM Pharmaceutical Holdings, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G